Link
Recommendations on the use of COVID-19 vaccine(s)
Organization: Public Health Agency of Canada (PHAC)Published: 2020
"The following highlights key, current information for immunization providers on COVID-19 vaccine. The evidence on COVID-19 disease and vaccines is evolving. Evidence from clinical trial data is limited due to limitations in the size and duration of follow-up of trial populations; however, studies are ongoing. NACI will continue to monitor the data and update its recommendations as needed. Please refer to the remainder of the Statement for details." - Recommendations on the use of COVID-19 vaccine(s)
Updated version available:
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Research and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Research and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Research and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Population: Seniors
High Risk Adults
Healthcare Personnel
Indigenous Populations
Region: National
Population: Seniors
High Risk Adults
Healthcare Personnel
Indigenous Populations
Region: National
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.